Atlas Trials

Dose-finding Study of Four Dosage Levels of an H7N9 Influenza Vaccine in Adults Between Ages of 18 Years and 65 Years

Clinical trial NCT01928472 · COMPLETED

Trial details

NCT number
NCT01928472
Sponsor
Novartis Vaccines
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
H7N9 Influenza
Start date
2013-08-01
Primary completion
2014-09-01
Enrollment
402

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.